Cholera vax trial
January 29, 2014
The Department of Health
Office of the Gene Technology
Regulator has invited comment
on a genetically modified cholera
vaccine clinical trial.
The regulator said it was assessing
a licence application from PaxVax
Australia Pty Ltd for the trial.
It would take place in Queensland,
South Australia, Victoria and
Western Australia, involving a
maximum of 1000 volunteer adults
and children, receiving an oral dose
of the vaccine and if approved, was
expected to finish within one year.
The regulator said it welcomed
written submissions, which would
be considered in finalising the Risk
Assessment and Risk Management
Plan, which would then inform the
decision as to whether to issue the
licence or not.
Submissions close on 06 Mar.
For more, CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Jan 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Jan 14
